Cita APA

Coccia, P. A., Alconcher, L., Ferraris, V., Lucarelli, L. I., Grillo, M. A., Arias, A., . . . Sánchez Luceros, A. G. (2024). Eculizumab as first line treatment for patients with severe presentation of Complement Factor H antibodies mediated Hemolytic Uremic Syndrome. Web

Citación estilo Chicago

Coccia, Paula Alejandra, et al. Eculizumab As First Line Treatment for Patients With Severe Presentation of Complement Factor H Antibodies Mediated Hemolytic Uremic Syndrome. 2024.

Cita MLA

Coccia, Paula Alejandra, et al. Eculizumab As First Line Treatment for Patients With Severe Presentation of Complement Factor H Antibodies Mediated Hemolytic Uremic Syndrome. 2024.